GLOBAL DERMATOLOGY ESSENTIALS: Psoriasis

Introducing the Event on Psoriasis at the end of October. The session will be chaired by Dr. Maria-Angeliki GKINI (UK / Greece)

We are pleased to announce an upcoming event focused on psoriasis, a chronic inflammatory dermatosis that affects millions of people worldwide. This event aims to bring together experts and researchers in the field of dermatology to discuss the latest advancements and research on psoriasis.

Psoriasis is a challenging condition that significantly impacts patients' quality of life. Over the years, traditional treatments have evolved to target specific inflammatory loops involved in psoriasis, such as anti-TNFalpha, anti-IL-17, IL-23, and small molecules like Aprémilast. The development of small molecules has opened new possibilities for effective and convenient treatment options.

During this event, renowned speakers and experts will present their insights on various aspects of psoriasis. The presentations will cover a wide range of topics, including general pustular psoriasis, current guidelines, and future treatments. Additionally, the event will focus on the role of teledermatology in the diagnosis and therapy of psoriasis, as well as the cardiovascular comorbidities associated with the condition.

Prof. Ahmed Samaouel CHEHAD MD from Algeria will provide an introduction to psoriasis and the importance of small molecules in its treatment.

Prof. Adam REICH MD, PhD from Poland will discuss the current guidelines and future treatments for general pustular psoriasis, shedding light on the promising role of anti-Interleukin-36 (IL-36) therapy. Dr. Maria-Angeliki GKINI from Switzerland will share valuable insights into the use of teledermatology in the diagnosis and therapy of psoriasis, highlighting its benefits in improving access to care.

Prof. Tiago TORRES MD, PhD from Portugal will delve into the relationship between psoriasis and cardiovascular comorbidities, exploring the potential of biological therapy in managing both skin symptoms and cardiovascular risk factors.

These presentations will provide attendees with a comprehensive understanding of psoriasis and its treatment options, focusing on the role of small molecules and other innovative approaches. The event will offer a unique opportunity for researchers, dermatologists, and healthcare professionals to exchange knowledge, discuss advancements, and foster collaborations in the field of psoriasis.

Please mark your calendars for the end of October to join us at this informative and enlightening event. Stay tuned for further updates on the event schedule and registration details.